In a phase 2 trial, treatment with sotatercept shows reduced pulmonary vascular resistance and heart outcomes in patients ...
WASHINGTON -- The novel investigational therapy seralutinib effectively reduced pulmonary vascular resistance (PVR) in patients with pulmonary arterial hypertension (PAH) on standard background ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The classification of “responder” was earned by ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A previous study found that seralutinib lowered ...
PAH therapies improved hemodynamic parameters and reduced NT-proBNP levels in PH-ILD patients, indicating potential benefits. Precision medicine could help identify PH-ILD patients who may benefit ...
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing ...
HONOLULU -- Are the updated European guidelines on pulmonary arterial hypertension (PAH) applicable to American practice? The European Society of Cardiology and European Respiratory Society guidelines ...
Shares of Insmed INSM soared nearly 29% yesterday after the company reported positive top-line data from a phase IIb study evaluating its investigational treprostinil palmitil inhalation powder (TPIP) ...
With the FDA expected this week to approve a first-in-class treatment from Merck for pulmonary arterial hypertension (PAH), Johnson & Johnson has beaten its New Jersey rival to the punch with a nod ...
Individualized treatment and close monitoring are essential for pregnant women with pulmonary hypertension due to high maternal and fetal risks. Prognosis in pulmonary hypertension varies with ...
Insmed Incorporated (INSM) is in a good position as a pharmaceutical company. It has already received regulatory approval in several territories for its drug known as ARIKAYCE which has been approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results